Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.

Also called NCT01763242

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 102 participants (enrolled count) (from the registry)
Sponsor
Western Health, Australia (from the registry)
Registry
  • NCT NCT01763242
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01763242. Randomized; no masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2012-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease
Acronym
EMAN-Anaemia
Condition
Kidney Failure, Chronic
Condition
Anemia
Intervention (Other)
EMAN
Lead sponsor
Western Health, Australia (class: other government)

Record details

Record id
cardio:ct-nct01763242
Content hash
ae55858b3a305c8a2801578de2d962f8cd4be9b79063d23854a67d2fb522da22